Spirographic AI Launches First Commercial Platform to Predict Per-Transporter Drug Exposure in Fetal and Breast Milk Compartments -- Achieving 96.4% and 93.7% Accuracy

The entire field predicts only whether a drug crosses — or estimates a bulk ratio. No commercial platform identifies which transporters are responsible, in which direction, or at what trimester. Spirographic AI does both — from SMILES input alone. CORVALLIS, Ore., April 7, 2026...